Allovir Inc (NASDAQ:ALVR)
| 3.76 Delayed Data As of May 27 |  +0.15 / +4.16%Today’s Change | 3.21 Today|||52-Week Range 26.41 | -70.94% Year-to-Date |
Latest ALVR News | Press Releases
No recent news for Allovir Inc.
Today’s Trading
| Previous close | 3.61 |
| Today’s open | 3.64 |
| Day’s range | 3.42 - 3.80 |
| Volume | 245,713 |
| Average volume (3 months) | 1,353,441 |
| Market cap | $254.5M |
Data as of 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -5.57% |
| Earnings growth (this year) | -2.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 1.10 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | September 7, 2022 |
| EPS forecast (this quarter) | -$0.70 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$172.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
